These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 21342067)

  • 1. An underestimated lentivirus model: what can HIV-2 research contribute to the development of an effective HIV-1 vaccine?
    Hodges-Mameletzis I; De Bree GJ; Rowland-Jones SL
    Expert Rev Anti Infect Ther; 2011 Feb; 9(2):195-206. PubMed ID: 21342067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toward an AIDS vaccine: lessons from natural simian immunodeficiency virus infections of African nonhuman primate hosts.
    Sodora DL; Allan JS; Apetrei C; Brenchley JM; Douek DC; Else JG; Estes JD; Hahn BH; Hirsch VM; Kaur A; Kirchhoff F; Muller-Trutwin M; Pandrea I; Schmitz JE; Silvestri G
    Nat Med; 2009 Aug; 15(8):861-5. PubMed ID: 19661993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced Simian Immunodeficiency Virus Replication in Macrophages of Sooty Mangabeys Is Associated with Increased Expression of Host Restriction Factors.
    Mir KD; Mavigner M; Wang C; Paiardini M; Sodora DL; Chahroudi AM; Bosinger SE; Silvestri G
    J Virol; 2015 Oct; 89(20):10136-44. PubMed ID: 26202248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonpathogenic simian immunodeficiency virus infection of sooty mangabeys is not associated with high levels of autologous neutralizing antibodies.
    Li B; Stefano-Cole K; Kuhrt DM; Gordon SN; Else JG; Mulenga J; Allen S; Sodora DL; Silvestri G; Derdeyn CA
    J Virol; 2010 Jun; 84(12):6248-53. PubMed ID: 20375163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Out of Africa: what can we learn from HIV-2 about protective immunity to HIV-1?
    Rowland-Jones SL; Whittle HC
    Nat Immunol; 2007 Apr; 8(4):329-31. PubMed ID: 17375091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lessons learnt from studies of the immune characterization of naturally SIV infected sooty mangabeys.
    Ansari AA; Onlamoon N; Bostik P; Mayne AE; Gargano L; Pattanapanyasat K
    Front Biosci; 2003 Sep; 8():s1030-50. PubMed ID: 12957849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simian immunodeficiency virus-induced alterations in monocyte production of tumor necrosis factor alpha contribute to reduced immune activation in sooty mangabeys.
    Mir KD; Bosinger SE; Gasper M; Ho O; Else JG; Brenchley JM; Kelvin DJ; Silvestri G; Hu SL; Sodora DL
    J Virol; 2012 Jul; 86(14):7605-15. PubMed ID: 22553338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Divergent host responses during primary simian immunodeficiency virus SIVsm infection of natural sooty mangabey and nonnatural rhesus macaque hosts.
    Silvestri G; Fedanov A; Germon S; Kozyr N; Kaiser WJ; Garber DA; McClure H; Feinberg MB; Staprans SI
    J Virol; 2005 Apr; 79(7):4043-54. PubMed ID: 15767406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic characterization of new West African simian immunodeficiency virus SIVsm: geographic clustering of household-derived SIV strains with human immunodeficiency virus type 2 subtypes and genetically diverse viruses from a single feral sooty mangabey troop.
    Chen Z; Telfier P; Gettie A; Reed P; Zhang L; Ho DD; Marx PA
    J Virol; 1996 Jun; 70(6):3617-27. PubMed ID: 8648696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Double-negative T cells during HIV/SIV infections: potential pinch hitters in the T-cell lineup.
    Sundaravaradan V; Mir KD; Sodora DL
    Curr Opin HIV AIDS; 2012 Mar; 7(2):164-71. PubMed ID: 22241163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A case for innate immune effector mechanisms as contributors to disease resistance in SIV-infected sooty mangabeys.
    Pereira LE; Ansari AA
    Curr HIV Res; 2009 Jan; 7(1):12-22. PubMed ID: 19149550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low-dose penile SIVmac251 exposure of rhesus macaques infected with adenovirus type 5 (Ad5) and then immunized with a replication-defective Ad5-based SIV gag/pol/nef vaccine recapitulates the results of the phase IIb step trial of a similar HIV-1 vaccine.
    Qureshi H; Ma ZM; Huang Y; Hodge G; Thomas MA; DiPasquale J; DeSilva V; Fritts L; Bett AJ; Casimiro DR; Shiver JW; Robert-Guroff M; Robertson MN; McChesney MB; Gilbert PB; Miller CJ
    J Virol; 2012 Feb; 86(4):2239-50. PubMed ID: 22156519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Classic AIDS in a sooty mangabey after an 18-year natural infection.
    Ling B; Apetrei C; Pandrea I; Veazey RS; Lackner AA; Gormus B; Marx PA
    J Virol; 2004 Aug; 78(16):8902-8. PubMed ID: 15280498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct inoculation of simian immunodeficiency virus from sooty mangabeys in black mangabeys (Lophocebus aterrimus): first evidence of AIDS in a heterologous African species and different pathologic outcomes of experimental infection.
    Apetrei C; Gormus B; Pandrea I; Metzger M; ten Haaft P; Martin LN; Bohm R; Alvarez X; Koopman G; Murphey-Corb M; Veazey RS; Lackner AA; Baskin G; Heeney J; Marx PA
    J Virol; 2004 Nov; 78(21):11506-18. PubMed ID: 15479792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Depletion of CD8+ cells in sooty mangabey monkeys naturally infected with simian immunodeficiency virus reveals limited role for immune control of virus replication in a natural host species.
    Barry AP; Silvestri G; Safrit JT; Sumpter B; Kozyr N; McClure HM; Staprans SI; Feinberg MB
    J Immunol; 2007 Jun; 178(12):8002-12. PubMed ID: 17548637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary SIVsm isolates use the CCR5 coreceptor from sooty mangabeys naturally infected in west Africa: a comparison of coreceptor usage of primary SIVsm, HIV-2, and SIVmac.
    Chen Z; Gettie A; Ho DD; Marx PA
    Virology; 1998 Jun; 246(1):113-24. PubMed ID: 9656999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunological changes in simian immunodeficiency virus (SIV(agm))-infected African green monkeys (AGM): expanded cytotoxic T lymphocyte, natural killer and B cell subsets in the natural host of SIV(agm).
    Holznagel E; Norley S; Holzammer S; Coulibaly C; Kurth R
    J Gen Virol; 2002 Mar; 83(Pt 3):631-640. PubMed ID: 11842258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathogenic Correlates of Simian Immunodeficiency Virus-Associated B Cell Dysfunction.
    Brocca-Cofano E; Kuhrt D; Siewe B; Xu C; Haret-Richter GS; Craigo J; Labranche C; Montefiori DC; Landay A; Apetrei C; Pandrea I
    J Virol; 2017 Dec; 91(23):. PubMed ID: 28931679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccine-based, long-term, stable control of simian/human immunodeficiency virus 89.6PD replication in rhesus macaques.
    Yamamoto H; Kawada M; Tsukamoto T; Takeda A; Igarashi H; Miyazawa M; Naruse T; Yasunami M; Kimura A; Matano T
    J Gen Virol; 2007 Feb; 88(Pt 2):652-659. PubMed ID: 17251584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. What can natural infection of African monkeys with simian immunodeficiency virus tell us about the pathogenesis of AIDS?
    Hirsch VM
    AIDS Rev; 2004; 6(1):40-53. PubMed ID: 15168740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.